Genenta Science S.p.A. Statistics
Share Statistics
Genenta Science S.p.A. has 18.29M shares outstanding. The number of shares has increased by 0.4% in one year.
| Shares Outstanding | 18.29M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.4% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 11.23M |
| Failed to Deliver (FTD) Shares | 459 |
| FTD / Avg. Volume | 3.67% |
Short Selling Information
The latest short interest is 3.07K, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 3.07K |
| Short % of Shares Out | 0.02% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 0.58 |
Valuation Ratios
The PE ratio is -7 and the forward PE ratio is -7.4.
| PE Ratio | -7 |
| Forward PE | -7.4 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 3.99 |
| P/FCF Ratio | -7.27 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Genenta Science S.p.A..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.25, with a Debt / Equity ratio of 0.
| Current Ratio | 12.25 |
| Quick Ratio | 12.25 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | -767782.86 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.57% and return on capital (ROIC) is -57.42%.
| Return on Equity (ROE) | -0.57% |
| Return on Assets (ROA) | -0.52% |
| Return on Capital (ROIC) | -57.42% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -831.82K |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -3.64% in the last 52 weeks. The beta is 0.74, so Genenta Science S.p.A.'s price volatility has been higher than the market average.
| Beta | 0.74 |
| 52-Week Price Change | -3.64% |
| 50-Day Moving Average | 4.96 |
| 200-Day Moving Average | 4.18 |
| Relative Strength Index (RSI) | 39.21 |
| Average Volume (20 Days) | 12.50K |
Income Statement
| Revenue | n/a |
| Gross Profit | -41.58K |
| Operating Income | -11.73M |
| Net Income | -11.65M |
| EBITDA | -11.69M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.64 |
Balance Sheet
The company has 3.69M in cash and 14.59 in debt, giving a net cash position of 3.69M.
| Cash & Cash Equivalents | 3.69M |
| Total Debt | 14.59 |
| Net Cash | 3.69M |
| Retained Earnings | -47.14M |
| Total Assets | 22.35M |
| Working Capital | 19.52M |
Cash Flow
In the last 12 months, operating cash flow was -11.21M and capital expenditures -13.79K, giving a free cash flow of -11.22M.
| Operating Cash Flow | -11.21M |
| Capital Expenditures | -13.79K |
| Free Cash Flow | -11.22M |
| FCF Per Share | -0.62 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GNTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -15.09% |
| FCF Yield | -14.48% |
Analyst Forecast
The average price target for GNTA is $25, which is 489.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $25 |
| Price Target Difference | 489.6% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 24.62 |
| Piotroski F-Score | 0 |